$VTR
Ventas, Inc.

2023 Q2 Form 10-Q Financial Statement

#000074026023000106 Filed on May 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $1.106B $1.077B
YoY Change 8.15% 5.87%
Cost Of Revenue $624.3M $609.6M
YoY Change 8.42% 12.06%
Gross Profit $482.1M $467.6M
YoY Change 7.81% -1.25%
Gross Profit Margin 43.58% 43.41%
Selling, General & Admin $34.40M $44.80M
YoY Change 4.51% 4.19%
% of Gross Profit 7.14% 9.58%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $304.7M $282.1M
YoY Change 7.64% -2.4%
% of Gross Profit 63.2% 60.33%
Operating Expenses $339.1M $318.3M
YoY Change 11.77% 0.17%
Operating Profit $143.0M $149.3M
YoY Change -0.53% -4.15%
Interest Expense -$112.0M $128.1M
YoY Change -198.3% 15.6%
% of Operating Profit -78.32% 85.79%
Other Income/Expense, Net $30.02M -$7.762M
YoY Change -162.4% -128.55%
Pretax Income $95.29M $11.53M
YoY Change -317.01% -69.59%
Income Tax -$9.773M -$2.802M
% Of Pretax Income -10.26% -24.3%
Net Earnings $103.5M $18.91M
YoY Change -351.09% -53.41%
Net Earnings / Revenue 9.35% 1.76%
Basic Earnings Per Share $0.26 $0.04
Diluted Earnings Per Share $0.26 $0.04
COMMON SHARES
Basic Shares Outstanding 400.1M shares 400.0M shares
Diluted Shares Outstanding 404.1M shares 403.8M shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $138.6M $145.4M
YoY Change 9.11% -2.84%
Cash & Equivalents $138.6M $145.4M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $138.6M $145.4M
YoY Change 9.11% -2.84%
LONG-TERM ASSETS
Property, Plant & Equipment $22.48B $21.00B
YoY Change 3.49% -4.47%
Goodwill $1.045B $1.045B
YoY Change 0.06% -0.09%
Intangibles
YoY Change
Long-Term Investments $629.2M $699.6M
YoY Change 6.57% 14.05%
Other Assets $99.71M $81.05M
YoY Change 8.52% -7.09%
Total Long-Term Assets $24.93B $23.85B
YoY Change 1.76% -3.84%
TOTAL ASSETS
Total Short-Term Assets $138.6M $145.4M
Total Long-Term Assets $24.93B $23.85B
Total Assets $25.07B $23.99B
YoY Change 1.8% -3.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.070B $1.007B
YoY Change 0.63% -6.68%
Accrued Expenses $313.8M $283.5M
YoY Change 5.05% -2.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.383B $1.291B
YoY Change 1.6% -5.69%
LONG-TERM LIABILITIES
Long-Term Debt $13.35B $12.34B
YoY Change 8.33% -0.57%
Other Long-Term Liabilities $2.959M $4.412M
YoY Change -49.6% -47.54%
Total Long-Term Liabilities $13.36B $12.35B
YoY Change 8.3% -0.61%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.383B $1.291B
Total Long-Term Liabilities $13.36B $12.35B
Total Liabilities $14.83B $13.67B
YoY Change 7.92% -1.26%
SHAREHOLDERS EQUITY
Retained Earnings -$5.688B -$5.611B
YoY Change 12.76% 16.37%
Common Stock $15.69B $15.66B
YoY Change 0.46% 0.54%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares 275.0K shares
Shareholders Equity $10.24B $9.997B
YoY Change
Total Liabilities & Shareholders Equity $25.07B $23.99B
YoY Change 1.8% -3.83%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $103.5M $18.91M
YoY Change -351.09% -53.41%
Depreciation, Depletion And Amortization $304.7M $282.1M
YoY Change 7.64% -2.4%
Cash From Operating Activities $311.8M $242.8M
YoY Change 12.14% -11.56%
INVESTING ACTIVITIES
Capital Expenditures $128.4M $112.7M
YoY Change -230.3% -251.58%
Acquisitions
YoY Change
Other Investing Activities $57.10M $56.38M
YoY Change -344.31% -115.53%
Cash From Investing Activities -$71.33M -$56.28M
YoY Change -41.5% -87.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -226.0M -$162.1M
YoY Change 26.72% -198.02%
NET CHANGE
Cash From Operating Activities 311.8M $242.8M
Cash From Investing Activities -71.33M -$56.28M
Cash From Financing Activities -226.0M -$162.1M
Net Change In Cash 14.52M $24.43M
YoY Change -165.46% 836.37%
FREE CASH FLOW
Cash From Operating Activities $311.8M $242.8M
Capital Expenditures $128.4M $112.7M
Free Cash Flow $183.4M $130.2M
YoY Change -51.31% -62.69%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000740260
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
1-10989
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Ventas, Inc.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
61-1055020
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
353 N. Clark Street
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 3300
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Chicago
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60654
CY2023Q1 dei City Area Code
CityAreaCode
877
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
483-6827
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock $0.25 par value
CY2023Q1 dei Trading Symbol
TradingSymbol
VTR
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
400051793 shares
CY2023Q1 us-gaap Land And Land Improvements
LandAndLandImprovements
2434312000 usd
CY2022Q4 us-gaap Land And Land Improvements
LandAndLandImprovements
2437905000 usd
CY2023Q1 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
26078611000 usd
CY2022Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
26020048000 usd
CY2023Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
335879000 usd
CY2022Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
310456000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1345415000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1346190000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
309113000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
310307000 usd
CY2023Q1 vtr Real Estate Investments Gross
RealEstateInvestmentsGross
30503330000 usd
CY2022Q4 vtr Real Estate Investments Gross
RealEstateInvestmentsGross
30424906000 usd
CY2023Q1 vtr Accumulated Depreciation And Amortization
AccumulatedDepreciationAndAmortization
9504021000 usd
CY2022Q4 vtr Accumulated Depreciation And Amortization
AccumulatedDepreciationAndAmortization
9264456000 usd
CY2023Q1 vtr Net Real Estate Property
NetRealEstateProperty
20999309000 usd
CY2022Q4 vtr Net Real Estate Property
NetRealEstateProperty
21160450000 usd
CY2023Q1 vtr Secured Notes And Loans Receivable Net
SecuredNotesAndLoansReceivableNet
501004000 usd
CY2022Q4 vtr Secured Notes And Loans Receivable Net
SecuredNotesAndLoansReceivableNet
537075000 usd
CY2023Q1 us-gaap Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures
RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures
606006000 usd
CY2022Q4 us-gaap Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures
RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures
579949000 usd
CY2023Q1 vtr Net Real Estate Investments
NetRealEstateInvestments
22106319000 usd
CY2022Q4 vtr Net Real Estate Investments
NetRealEstateInvestments
22277474000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
145357000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
122564000 usd
CY2023Q1 vtr Escrow Deposits And Restricted Cash
EscrowDepositsAndRestrictedCash
49924000 usd
CY2022Q4 vtr Escrow Deposits And Restricted Cash
EscrowDepositsAndRestrictedCash
48181000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
1044699000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
1044415000 usd
CY2023Q1 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
20233000 usd
CY2022Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
44893000 usd
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
10889000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
10490000 usd
CY2023Q1 us-gaap Other Assets
OtherAssets
616747000 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
609823000 usd
CY2023Q1 us-gaap Assets
Assets
23994168000 usd
CY2022Q4 us-gaap Assets
Assets
24157840000 usd
CY2023Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
12342506000 usd
CY2022Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
12296780000 usd
CY2023Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
93543000 usd
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
110542000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
189911000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
190440000 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
1007437000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
1031689000 usd
CY2023Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
4412000 usd
CY2022Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
6492000 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
31871000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
35570000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
13669680000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
13671513000 usd
CY2023Q1 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
259886000 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
264650000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.25
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.25
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
400055000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
400055000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
399707000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
399707000 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
100065000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
99912000 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
15562017000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
15539777000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-40469000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-36800000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5611067000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5449385000 usd
CY2023Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
275000 shares
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
10000 shares
CY2023Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
13555000 usd
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
536000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
9996991000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
10152968000 usd
CY2023Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
14500000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
67611000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
68709000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10064602000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10221677000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23994168000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24157840000 usd
CY2023Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
352743000 usd
CY2022Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
352101000 usd
CY2023Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
13589000 usd
CY2022Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
9847000 usd
CY2023Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
1743000 usd
CY2022Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
536000 usd
CY2023Q1 us-gaap Revenues
Revenues
1077245000 usd
CY2022Q1 us-gaap Revenues
Revenues
1017554000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
128075000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
110794000 usd
CY2023Q1 vtr Commercial Paper Program Capacity
CommercialPaperProgramCapacity
1000000000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
282119000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
289064000 usd
CY2023Q1 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
607931000 usd
CY2022Q1 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
542721000 usd
CY2023Q1 us-gaap Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
1706000 usd
CY2022Q1 us-gaap Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
1313000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
44798000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
42998000 usd
CY2023Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1386000 usd
CY2022Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
19992000 usd
CY2023Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-8064000 usd
CY2022Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-54000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7762000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
27190000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
1065713000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
979638000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11532000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
37916000 usd
CY2023Q1 vtr Income Loss From Equity Method Investments And Remeasurement Gain On Equity Interest In Acquiree
IncomeLossFromEquityMethodInvestmentsAndRemeasurementGainOnEquityInterestInAcquiree
-5623000 usd
CY2022Q1 vtr Income Loss From Equity Method Investments And Remeasurement Gain On Equity Interest In Acquiree
IncomeLossFromEquityMethodInvestmentsAndRemeasurementGainOnEquityInterestInAcquiree
-4269000 usd
CY2023Q1 vtr Gain Loss On Disposition Of Real Estate
GainLossOnDispositionOfRealEstate
10201000 usd
CY2022Q1 vtr Gain Loss On Disposition Of Real Estate
GainLossOnDispositionOfRealEstate
2455000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2802000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4490000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
18912000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
40592000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
18912000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
40592000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1395000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1860000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
17517000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
38732000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4903000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
9135000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.05
CY2022Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.10
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.05
CY2022Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.10
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2023Q1 us-gaap Profit Loss
ProfitLoss
18912000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
40592000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
3899000 usd
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-9313000 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 usd
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-588000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-8802000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
19036000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
14009000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
49727000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
161000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
5772000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13848000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
43955000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10221677000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
18912000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4903000 usd
CY2023Q1 vtr Noncontrolling Interest Period Increase Decrease Including Impact To Equity
NoncontrollingInterestPeriodIncreaseDecreaseIncludingImpactToEquity
-134000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.45
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
179199000 usd
CY2023Q1 vtr Stock Issued During Period Value Share Based Payment Arrangements Restricted Stock Awards And Other After Forfeiture
StockIssuedDuringPeriodValueShareBasedPaymentArrangementsRestrictedStockAwardsAndOtherAfterForfeiture
4973000 usd
CY2023Q1 vtr Adjustments To Additional Paid In Capital Related To Redeemable Operating Partner Unitholder Interests To Record At Fair Value
AdjustmentsToAdditionalPaidInCapitalRelatedToRedeemableOperatingPartnerUnitholderInterestsToRecordAtFairValue
3077000 usd
CY2023Q1 vtr Adjustments To Equity Redemption Of Limited Partnership Units
AdjustmentsToEquityRedemptionOfLimitedPartnershipUnits
-69000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10064602000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10945760000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
40592000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
9135000 usd
CY2022Q1 vtr Noncontrolling Interest Period Increase Decrease Including Impact To Equity
NoncontrollingInterestPeriodIncreaseDecreaseIncludingImpactToEquity
1004000 usd
CY2022Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.45
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
180496000 usd
CY2022Q1 vtr Stock Issued During Period Value Share Based Payment Arrangements Restricted Stock Awards And Other After Forfeiture
StockIssuedDuringPeriodValueShareBasedPaymentArrangementsRestrictedStockAwardsAndOtherAfterForfeiture
15340000 usd
CY2022Q1 vtr Adjustments To Additional Paid In Capital Related To Redeemable Operating Partner Unitholder Interests To Record At Fair Value
AdjustmentsToAdditionalPaidInCapitalRelatedToRedeemableOperatingPartnerUnitholderInterestsToRecordAtFairValue
-36637000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10792690000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
18912000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
40592000 usd
CY2023Q1 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
282119000 usd
CY2022Q1 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
289064000 usd
CY2023Q1 vtr Amortization Of Deferred Revenue And Lease Intangibles
AmortizationOfDeferredRevenueAndLeaseIntangibles
-14913000 usd
CY2022Q1 vtr Amortization Of Deferred Revenue And Lease Intangibles
AmortizationOfDeferredRevenueAndLeaseIntangibles
-17401000 usd
CY2023Q1 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
4154000 usd
CY2022Q1 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
3109000 usd
CY2023Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-8064000 usd
CY2022Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-54000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
15060000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
15796000 usd
CY2023Q1 us-gaap Straight Line Rent
StraightLineRent
445000 usd
CY2022Q1 us-gaap Straight Line Rent
StraightLineRent
3841000 usd
CY2023Q1 vtr Gain Loss On Disposition Of Real Estate
GainLossOnDispositionOfRealEstate
10201000 usd
CY2022Q1 vtr Gain Loss On Disposition Of Real Estate
GainLossOnDispositionOfRealEstate
2455000 usd
CY2023Q1 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
-4299000 usd
CY2022Q1 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
-5805000 usd
CY2023Q1 vtr Income Loss From Equity Method Investments And Other Items Non Cash Portion
IncomeLossFromEquityMethodInvestmentsAndOtherItemsNonCashPortion
-5623000 usd
CY2022Q1 vtr Income Loss From Equity Method Investments And Other Items Non Cash Portion
IncomeLossFromEquityMethodInvestmentsAndOtherItemsNonCashPortion
-4269000 usd
CY2023Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
5472000 usd
CY2022Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
4356000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1526000 usd
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
24324000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
16885000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
18177000 usd
CY2023Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-17006000 usd
CY2022Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-13201000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-18236000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2625000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
242817000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
274553000 usd
CY2023Q1 us-gaap Payments To Acquire Commercial Real Estate
PaymentsToAcquireCommercialRealEstate
0 usd
CY2022Q1 us-gaap Payments To Acquire Commercial Real Estate
PaymentsToAcquireCommercialRealEstate
343792000 usd
CY2023Q1 us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
289000 usd
CY2022Q1 us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
5117000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
46417000 usd
CY2022Q1 us-gaap Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
6124000 usd
CY2023Q1 us-gaap Proceeds From Sale And Collection Of Loans Receivable
ProceedsFromSaleAndCollectionOfLoansReceivable
44354000 usd
CY2022Q1 us-gaap Proceeds From Sale And Collection Of Loans Receivable
ProceedsFromSaleAndCollectionOfLoansReceivable
177000 usd
CY2023Q1 us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
69079000 usd
CY2022Q1 us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
37591000 usd
CY2023Q1 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
43577000 usd
CY2022Q1 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
36728000 usd
CY2023Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
35792000 usd
CY2022Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
23790000 usd
CY2023Q1 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
1686000 usd
CY2022Q1 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
3391000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-56280000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-437326000 usd
CY2023Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
14340000 usd
CY2022Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-9867000 usd
CY2023Q1 us-gaap Proceeds From Repayments Of Commercial Paper
ProceedsFromRepaymentsOfCommercialPaper
22164000 usd
CY2022Q1 us-gaap Proceeds From Repayments Of Commercial Paper
ProceedsFromRepaymentsOfCommercialPaper
356674000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
343900000 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
70029000 usd
CY2023Q1 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
343876000 usd
CY2022Q1 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
65000000 usd
CY2023Q1 vtr Payments For Noncontrolling Interests
PaymentsForNoncontrollingInterests
110000 usd
CY2022Q1 vtr Payments For Noncontrolling Interests
PaymentsForNoncontrollingInterests
170000 usd
CY2023Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
4027000 usd
CY2022Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
427000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
181422000 usd
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
180021000 usd
CY2023Q1 vtr Cash Distributions To Redeemable Op Unitholders
CashDistributionsToRedeemableOPUnitholders
1539000 usd
CY2022Q1 vtr Cash Distributions To Redeemable Op Unitholders
CashDistributionsToRedeemableOPUnitholders
1534000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
655000 usd
CY2022Q1 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
0 usd
CY2023Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
2973000 usd
CY2022Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
19000 usd
CY2023Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
2566000 usd
CY2022Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
3983000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1736000 usd
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5794000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-13025000 usd
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-6132000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-162107000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
165382000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
24430000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2609000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
106000 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
241000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
170745000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
196597000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
195281000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
199447000 usd
CY2023Q1 us-gaap Transfer Of Investments
TransferOfInvestments
0 usd
CY2022Q1 us-gaap Transfer Of Investments
TransferOfInvestments
3171000 usd
CY2023Q1 us-gaap Noncash Or Part Noncash Acquisition Other Assets Acquired1
NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1
0 usd
CY2022Q1 us-gaap Noncash Or Part Noncash Acquisition Other Assets Acquired1
NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1
47000 usd
CY2023Q1 us-gaap Noncash Or Part Noncash Acquisition Other Liabilities Assumed1
NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1
0 usd
CY2022Q1 us-gaap Noncash Or Part Noncash Acquisition Other Liabilities Assumed1
NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1
2624000 usd
CY2023Q1 vtr Noncash Or Part Noncash Acquisition Deferred Income Tax Liabilities Assumed
NoncashOrPartNoncashAcquisitionDeferredIncomeTaxLiabilitiesAssumed
0 usd
CY2022Q1 vtr Noncash Or Part Noncash Acquisition Deferred Income Tax Liabilities Assumed
NoncashOrPartNoncashAcquisitionDeferredIncomeTaxLiabilitiesAssumed
594000 usd
CY2023Q1 us-gaap Nature Of Operations
NatureOfOperations
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 1—DESCRIPTION OF BUSINESS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ventas, Inc. (together with its consolidated subsidiaries, unless otherwise indicated or except where the context otherwise requires, “we,” “us,” “our,” “Company” and other similar terms), an S&amp;P 500 company, is a real estate investment trust (“REIT”) operating at the intersection of healthcare and real estate. We hold a highly diversified portfolio of senior housing communities, medical office buildings (“MOBs”), life science, research and innovation centers, hospitals and other healthcare facilities, which we generally refer to collectively as “healthcare real estate,” located throughout the United States, Canada and the United Kingdom. As of March 31, 2023, we owned or had investments in approximately 1,200 properties (including properties classified as held for sale). Our company was originally founded in 1983 and is headquartered in Chicago, Illinois with additional corporate offices in Louisville, Kentucky and New York, New York. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We primarily invest in a diversified portfolio of healthcare real estate assets through wholly owned subsidiaries and other co-investment entities. We operate through three reportable business segments: triple-net leased properties, senior housing operating portfolio, which we also refer to as “SHOP” and which was formerly known as senior living operations, and office operations. See “Note 2 – Accounting Policies” and “Note 15 – Segment Information.” Our senior housing communities are either subject to triple-net leases, in which case they are included in our triple-net leased properties reportable business segment, or operated by independent third-party managers, in which case they are included in our SHOP reportable business segment. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, we leased a total of 312 properties (excluding properties within our office operations reportable business segment) to various healthcare operating companies under triple-net or absolute-net leases that obligate the tenants to pay all property-related expenses, including maintenance, utilities, repairs, taxes, insurance and capital expenditures. Our three largest tenants, Brookdale Senior Living Inc. (together with its subsidiaries, “Brookdale Senior Living”), Ardent Health Partners, LLC (together with its subsidiaries, “Ardent”) and Kindred Healthcare, LLC (together with its subsidiaries, “Kindred”) leased from us 121 properties, 30 properties (including 19 MOBs) and 29 properties, respectively, as of March 31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, pursuant to long-term management agreements, we engaged independent operators, such as Atria Senior Living, Inc. (together with its subsidiaries, including Holiday Retirement (“Holiday”), “Atria”) and Sunrise Senior Living, LLC (together with its subsidiaries, “Sunrise”), to manage 560 senior housing communities. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, we owned or had investments in a total of 373 properties in our office operations reportable business segment. These properties generally consist of MOBs that are predominantly located on or contiguous to a health system campus and life science, research and innovation properties that are affiliated with and often located on or contiguous to a university or academic medical campus. Through our Lillibridge Healthcare Services, Inc. subsidiary and our ownership interest in PMB Real Estate Services LLC, we also provide MOB management, leasing, marketing, facility development and advisory services to highly rated hospitals and health systems throughout the United States. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, from time to time, we make secured and unsecured loans and other investments relating to healthcare real estate or operators. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a third-party institutional capital management business, Ventas Investment Management (“VIM”), which includes our open-ended investment vehicle, the Ventas Life Science &amp; Healthcare Real Estate Fund (the “Ventas Fund”). Through VIM, we partner with third-party institutional investors to invest in healthcare real estate through various joint ventures and other co-investment vehicles where we are the sponsor or general partner.</span></div>
CY2023Q1 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
1200 property
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2023Q1 vtr Concentration Risk Number Of Tenants
ConcentrationRiskNumberOfTenants
3 tenant
CY2023Q1 vtr Secured Loans Unsecured Loans And Other Available For Sale Securities Fair Value
SecuredLoansUnsecuredLoansAndOtherAvailableForSaleSecuritiesFairValue
524658000 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Estimates</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with GAAP requires us to make estimates and assumptions regarding future events that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></div>
CY2022Q4 vtr Secured Loans Unsecured Loans And Other Available For Sale Securities Amortized Cost
SecuredLoansUnsecuredLoansAndOtherAvailableForSaleSecuritiesAmortizedCost
586034000 usd
CY2023Q1 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
20233000 usd
CY2023Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
4412000 usd
CY2022Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
44893000 usd
CY2022Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
6492000 usd
CY2023Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
8600000 usd
CY2022Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
14300000 usd
CY2023Q1 vtr Secured Loans Unsecured Loans And Other Available For Sale Securities
SecuredLoansUnsecuredLoansAndOtherAvailableForSaleSecurities
525400000 usd
CY2022Q4 vtr Secured Loans Unsecured Loans And Other Available For Sale Securities
SecuredLoansUnsecuredLoansAndOtherAvailableForSaleSecurities
561400000 usd
CY2023Q1 vtr Secured Loans Unsecured Loans And Other Available For Sale Securities Amortized Cost
SecuredLoansUnsecuredLoansAndOtherAvailableForSaleSecuritiesAmortizedCost
541979000 usd
CY2023Q1 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAllowanceForCreditLoss
16557000 usd
CY2023Q1 vtr Secured Loans Unsecured Loans And Other Available For Sale Securities
SecuredLoansUnsecuredLoansAndOtherAvailableForSaleSecurities
525422000 usd
CY2022Q4 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAllowanceForCreditLoss
24621000 usd
CY2022Q4 vtr Secured Loans Unsecured Loans And Other Available For Sale Securities
SecuredLoansUnsecuredLoansAndOtherAvailableForSaleSecurities
561413000 usd
CY2022Q4 vtr Secured Loans Unsecured Loans And Other Available For Sale Securities Fair Value
SecuredLoansUnsecuredLoansAndOtherAvailableForSaleSecuritiesFairValue
560449000 usd
CY2023Q1 us-gaap Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures
RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures
606006000 usd
CY2022Q4 us-gaap Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures
RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures
579949000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
1044699000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
1044415000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1093129000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1061305000 usd
CY2023Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
1331393000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P8Y1M6D
CY2022Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
1363704000 usd
us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P7Y9M18D
CY2023Q1 us-gaap Below Market Lease Gross
BelowMarketLeaseGross
333652000 usd
CY2023Q1 vtr Finite Lived Intangible Liabilities Below Market Leases Remaining Weighted Average Amortization Period
FiniteLivedIntangibleLiabilitiesBelowMarketLeasesRemainingWeightedAverageAmortizationPeriod
P8Y6M
CY2022Q4 us-gaap Below Market Lease Gross
BelowMarketLeaseGross
333672000 usd
vtr Finite Lived Intangible Liabilities Below Market Leases Remaining Weighted Average Amortization Period
FiniteLivedIntangibleLiabilitiesBelowMarketLeasesRemainingWeightedAverageAmortizationPeriod
P8Y7M6D
CY2023Q1 vtr Other Finite Lived Intangible Liabilities Gross
OtherFiniteLivedIntangibleLiabilitiesGross
13498000 usd
CY2022Q4 vtr Other Finite Lived Intangible Liabilities Gross
OtherFiniteLivedIntangibleLiabilitiesGross
13498000 usd
CY2023Q1 vtr Finite Lived Intangible Liabilities Accumulated Amortization
FiniteLivedIntangibleLiabilitiesAccumulatedAmortization
262169000 usd
CY2022Q4 vtr Finite Lived Intangible Liabilities Accumulated Amortization
FiniteLivedIntangibleLiabilitiesAccumulatedAmortization
258639000 usd
CY2023Q1 vtr Indefinite Lived Intangible Liabilities Purchase Options
IndefiniteLivedIntangibleLiabilitiesPurchaseOptions
3568000 usd
CY2022Q4 vtr Indefinite Lived Intangible Liabilities Purchase Options
IndefiniteLivedIntangibleLiabilitiesPurchaseOptions
3568000 usd
CY2023Q1 vtr Finite And Indefinite Lived Intangible Liabilities Net
FiniteAndIndefiniteLivedIntangibleLiabilitiesNet
88549000 usd
CY2023Q1 vtr Finite Lived Intangible Liabilities Remaining Weighted Average Amortization Period
FiniteLivedIntangibleLiabilitiesRemainingWeightedAverageAmortizationPeriod
P8Y6M
CY2022Q4 vtr Finite And Indefinite Lived Intangible Liabilities Net
FiniteAndIndefiniteLivedIntangibleLiabilitiesNet
92099000 usd
vtr Finite Lived Intangible Liabilities Remaining Weighted Average Amortization Period
FiniteLivedIntangibleLiabilitiesRemainingWeightedAverageAmortizationPeriod
P8Y7M6D
CY2022Q4 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
272572000 usd
CY2023Q1 vtr Deferred Rent Receivable
DeferredRentReceivable
190635000 usd
CY2022Q4 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
187536000 usd
CY2023Q1 vtr Non Mortgage Loans Receivable Net
NonMortgageLoansReceivableNet
24418000 usd
CY2022Q4 vtr Non Mortgage Loans Receivable Net
NonMortgageLoansReceivableNet
24338000 usd
CY2023Q1 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
6189000 usd
CY2022Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
6393000 usd
CY2023Q1 vtr Investment In Unconsolidated Operating Entities
InvestmentInUnconsolidatedOperatingEntities
93609000 usd
CY2022Q4 vtr Investment In Unconsolidated Operating Entities
InvestmentInUnconsolidatedOperatingEntities
95363000 usd
CY2023Q1 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
277304000 usd
CY2023Q1 us-gaap Other Assets
OtherAssets
616747000 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
609823000 usd
CY2023Q1 us-gaap Commercial Paper
CommercialPaper
425000000 usd
CY2022Q4 us-gaap Commercial Paper
CommercialPaper
403000000 usd
CY2023Q1 vtr Long Term Debt And Short Term Borrowings Gross
LongTermDebtAndShortTermBorrowingsGross
12406943000 usd
CY2022Q4 vtr Long Term Debt And Short Term Borrowings Gross
LongTermDebtAndShortTermBorrowingsGross
12361244000 usd
CY2023Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
62321000 usd
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
63410000 usd
CY2023Q1 vtr Debt Instrument Unamortized Fair Value Adjustment
DebtInstrumentUnamortizedFairValueAdjustment
21485000 usd
CY2022Q4 vtr Debt Instrument Unamortized Fair Value Adjustment
DebtInstrumentUnamortizedFairValueAdjustment
23535000 usd
CY2023Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
23601000 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
24589000 usd
CY2023Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
12342506000 usd
CY2022Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
12296780000 usd
CY2023Q1 us-gaap Commercial Paper
CommercialPaper
425000000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
173270000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
1753447000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
2526562000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
1087089000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
1366396000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
5500179000 usd
CY2023Q1 vtr Long Term Debt And Short Term Borrowings Gross
LongTermDebtAndShortTermBorrowingsGross
12406943000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
145400000 usd
CY2023Q1 vtr Long Term Debt And Short Term Borrowings Gross
LongTermDebtAndShortTermBorrowingsGross
12406943000 usd
CY2022Q4 vtr Long Term Debt And Short Term Borrowings Gross
LongTermDebtAndShortTermBorrowingsGross
12361244000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
18912000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
40592000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.10
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2800000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4500000 usd
CY2022Q1 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
2000000 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
31900000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
35600000 usd
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
10900000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
10500000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1395000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1860000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
17517000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-56730000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-60364000 usd
CY2023Q1 us-gaap Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax
AociLossCashFlowHedgeCumulativeGainLossAfterTax
16261000 usd
CY2022Q4 us-gaap Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax
AociLossCashFlowHedgeCumulativeGainLossAfterTax
23564000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-40469000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-36800000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
18912000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
40592000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
38732000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
399989000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
399297000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
25000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
320000 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
421000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
3483000 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
3517000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
403792000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
403260000 shares
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.05
CY2022Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.10
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.05
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2023Q1 vtr Intersegment Sales And Transfers
IntersegmentSalesAndTransfers
0 usd
CY2023Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
352743000 usd
CY2023Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
13589000 usd
CY2023Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
1743000 usd
CY2023Q1 us-gaap Revenues
Revenues
1077245000 usd
CY2023Q1 us-gaap Revenues
Revenues
1077245000 usd
CY2023Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
1743000 usd
CY2023Q1 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
607931000 usd
CY2023Q1 us-gaap Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
1706000 usd
CY2023Q1 vtr Net Operating Income
NetOperatingIncome
465865000 usd
CY2023Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
1743000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
128075000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
282119000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
44798000 usd
CY2023Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1386000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
-8064000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7762000 usd
CY2023Q1 vtr Income Loss From Equity Method Investments And Remeasurement Gain On Equity Interest In Acquiree
IncomeLossFromEquityMethodInvestmentsAndRemeasurementGainOnEquityInterestInAcquiree
-5623000 usd
CY2023Q1 vtr Gain Loss On Disposition Of Real Estate
GainLossOnDispositionOfRealEstate
10201000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2802000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
18912000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
18912000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1395000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
17517000 usd
CY2022Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
352101000 usd
CY2022Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
9847000 usd
CY2022Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
536000 usd
CY2022Q1 us-gaap Revenues
Revenues
1017554000 usd
CY2022Q1 us-gaap Revenues
Revenues
1017554000 usd
CY2022Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
536000 usd
CY2022Q1 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
542721000 usd
CY2022Q1 us-gaap Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
1313000 usd
CY2022Q1 vtr Net Operating Income
NetOperatingIncome
472984000 usd
CY2022Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
536000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
110794000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
289064000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
42998000 usd
CY2022Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
19992000 usd
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
-54000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
27190000 usd
CY2022Q1 vtr Income Loss From Equity Method Investments And Remeasurement Gain On Equity Interest In Acquiree
IncomeLossFromEquityMethodInvestmentsAndRemeasurementGainOnEquityInterestInAcquiree
-4269000 usd
CY2022Q1 vtr Gain Loss On Disposition Of Real Estate
GainLossOnDispositionOfRealEstate
2455000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4490000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
40592000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
40592000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1860000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
38732000 usd
CY2023Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
112656000 usd
CY2022Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
418111000 usd
CY2023Q1 us-gaap Revenues
Revenues
1077245000 usd
CY2022Q1 us-gaap Revenues
Revenues
1017554000 usd
CY2023Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
20999309000 usd
CY2022Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
21160450000 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
vtr-20230331_cal.xml Edgar Link unprocessable
0000740260-23-000106-index-headers.html Edgar Link pending
0000740260-23-000106-index.html Edgar Link pending
0000740260-23-000106.txt Edgar Link pending
0000740260-23-000106-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vtr-20230331.htm Edgar Link pending
vtr-20230331.xsd Edgar Link pending
vtr-ex22_033123.htm Edgar Link pending
vtr-ex311_033123.htm Edgar Link pending
vtr-ex312_033123.htm Edgar Link pending
vtr-ex321_033123.htm Edgar Link pending
vtr-ex322_033123.htm Edgar Link pending
vtr-ex41ninthsuppindenture.htm Edgar Link pending
vtr-20230331_def.xml Edgar Link unprocessable
vtr-20230331_lab.xml Edgar Link unprocessable
vtr-20230331_pre.xml Edgar Link unprocessable
vtr-20230331_htm.xml Edgar Link completed